share_log

EF Hutton Reiterates Buy on HCW Biologics, Maintains $9 Price Target

Benzinga ·  Mar 30, 2023 07:29

EF Hutton analyst Constantine Davides reiterates HCW Biologics (NASDAQ:HCWB) with a Buy and maintains $9 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment